MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    How Feasible and Valuable is Home Lying Standing Blood Pressure Monitoring in People with Parkinsonism?

    K. Lloyd, S. Haworth, M. Nogradi, C. Glover, EJ. Henderson (Bristol, United Kingdom)

    Objective: To evaluate the feasibility and value of home lying-standing blood pressure monitoring in the detection of orthostatic hypotension (OH) in people with parkinsonism (PwP).…
  • 2025 International Congress

    Unveiling Parkinson’s Disease Variants in the Chinese Population: The CPD10KGP Study

    Y. Zhao, Z. Liu, H. Pan, J. Guo, B. Tang (Changsha, China)

    Objective: In response to these limitations, we are proposing the China Parkinson’s Disease 10,000 Genomes Project (CPD10KGP), which aims to delineate the genetic architecture of…
  • 2025 International Congress

    Role of 7-Tesla MRI in assessing clinical symptoms in CSF1R-Related Disorders

    T. Chmiela, J. Dulski, A. Strongosky, E. Middlebrooks, Z. Wszolek (Katowice, Poland)

    Objective: To evaluate utility of 7-tesla magnetic resonance imaging (7T MRI) as a biomarker of CSR1R-Related Disorder (CSF1R-RD). Background: CSF1R-RD is a rapidly progressive neurodegenerative…
  • 2025 International Congress

    Exploring the Association of APOE Polymorphism and the Clinical Course of CSF1R-Related Disorder

    A. Strongosky, T. Chmiela, M. Baker, Z. Wszolek (Jacksonville, USA)

    Objective: To assess the frequency of APOE alleles and their association with clinical course of Colony Stimulating Factor 1 Receptor-Related Disorder (CSF1R-RD). Background: CSF1R-RD is…
  • 2025 International Congress

    Beyond Neurodegeneration: Anti-Recoverin Autoantibodies in Immune-Mediated Parkinsonism

    A. Sultana, N. Anam, S. Kamat, F. Ansari, A. Vyas, S. Wagh (Mumbai, India)

    Objective: To report a rare case of autoimmune Parkinsonism associated with anti-recoverin antibodies, highlighting atypical presentation , diagnostic challenges and immunotherapy response. Background: Parkinsonism is…
  • 2025 International Congress

    Differentiating White-Matter Damage Patterns by Underlying Pathology in Corticobasal Syndrome

    J. Parmera, A. Hernandez, B. Iepsen, C. Carneiro, S. Brucki, A. Coutinho (São Paulo, Brazil)

    Objective: This study aims to describe the patterns of white-matter damage using diffusion tensor imaging (DTI) in individuals with Corticobasal Syndrome (CBS) and compare the…
  • 2025 International Congress

    Identification of Cerebrotendinous Xanthomatosis in Patients with Neurodegenerative Disorders from the Cincinnati Cohort Biomarker Program

    L. Marsili, M. Kauffman, K. Duque, J. Abanto, R. Dutta, T. Pramparo, J. Terner-Rosenthal, A. Espay (Cincinnati, USA)

    Objective: To develop an algorithm for identifying patients with cerebrotendinous xanthomatosis (CTX) in a cohort of individuals with neurodegenerative disorders. Background: CTX is a rare…
  • 2025 International Congress

    Transformation of Parkinson’s care through Self-Management, Remote monitoring and Timely review (SMaRT-PD): Care Pathway Mapping with Clinical Experts

    N. Howe, P. Walker, C. Mutepfa, S. Pretorius, A. Ponzo, C. Carroll, J. Suklan (Plymouth, United Kingdom)

    Objective: To elicit healthcare professionals’ perspectives on the introduction of a clinical decision support system (CDSS) to facilitate Parkinson’s disease care provision: impact on current…
  • 2025 International Congress

    Updated Meta-analysis Assessing GLP-1 Agonists for Parkinson’s Disease

    M. Messak, A. Abdelmageed, Y. Khattab (Helwan, Egypt)

    Objective: Evaluate the efficacy and safety of Glucagon-like peptide-1 (GLP-1) agonists on Parkinson’s disease (PD). Background: The idea of ​​repositioning drugs used to treat PD…
  • 2025 International Congress

    Predictors of suicidal ideation amongst people with parkinsonism in the PRIME-UK cross-sectional study

    S. Haworth, A. Nodehi, Y. Ben-Shlomo, E. Henderson, E. Tenison (Bristol, United Kingdom)

    Objective: To assess the frequency of, and predictors of, suicidal ideation (SI) in people with parkinsonism (PwP). Background: Both the neuropsychiatric and motor features, coupled…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley